Precision Biosciences (DTIL) Other Working Capital Changes (2018 - 2026)
Precision Biosciences (DTIL) reported Other Working Capital Changes of -$357000.0 for Q1 2026, down 1328.0% year-over-year from $29071.7 in Q1 2025, and up 98.61% quarter-over-quarter from -$25.7 million in Q4 2025.
Precision Biosciences (DTIL) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Other Working Capital Changes data on file, last reported at -$357000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$357000.0, down 1328.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.6 million (down 3887.61% YoY), and the FY2025 annual result was -$26.3 million, down 5758.84% from the prior year.
- Other Working Capital Changes rose to -$357000.0 in Q1 2026 per DTIL's latest filing, from -$25.7 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $46.7 million in Q2 2022 and troughed at -$36.2 million in Q4 2022.
- A 5-year average of -$1.5 million and a median of -$357000.0 in 2026 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes jumped 751.93% in 2022, then sank 3714.71% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$36.2 million in 2022, then surged by 99.43% to -$207000.0 in 2023, then tumbled by 225.12% to -$673000.0 in 2024, then slumped by 3714.71% to -$25.7 million in 2025, then jumped by 98.61% to -$357000.0 in 2026.
- Business Quant data shows DTIL's Other Working Capital Changes at -$357000.0 in Q1 2026, -$25.7 million in Q4 2025, and -$541000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -357,000.00 |
| Mar 31, 2026 | -357,000.00 |
| Dec 31, 2025 | -25.67 Mn |
| Dec 31, 2025 | -25.67 Mn |
| Sep 30, 2025 | -541,000.00 |
| Sep 30, 2025 | -541,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | -25,000.00 |
| Mar 31, 2025 | -25,000.00 |
| Dec 31, 2024 | -673,000.00 |
| Dec 31, 2024 | -673,000.00 |
| Sep 30, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Mar 31, 2024 | -263,000.00 |
| Mar 31, 2024 | -263,000.00 |
| Dec 31, 2023 | -207,000.00 |
| Dec 31, 2023 | -207,000.00 |